Skip to content

Clinical trials

Observational Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Observational Country / region: China Clear all

270 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20104
20124
20137
20146
20159
201611
201720
201822
201916
202028
202119
202221
202327
202425
202534
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status91
Completed69
Recruiting64
Active, not recruiting18
Not yet recruiting12
Enrolling by invitation6
Terminated5
Withdrawn4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hunan Province Tumor Hospital17
Sun Yat-sen University15
AstraZeneca14
Fudan University13
Peking University People's Hospital12
Cancer Institute and Hospital, Chinese Academy of Medical Sciences11
Shanghai Pulmonary Hospital, Shanghai, China11
Guangdong Association of Clinical Trials8
Shanghai Chest Hospital8
Guangdong Provincial People's Hospital5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung270
Lung Neoplasms54
Adenocarcinoma of Lung9
Carcinoma9
Brain Neoplasms6
Neoplasms6
Bronchial Neoplasms5
Carcinoma, Bronchogenic5
Lung Diseases5
Lymphatic Metastasis4

Trials

Showing 1 to 25 of 270. Each trial links to its page on Pharma Observatory.

170 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.